A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic cancer with arterial involvement
| Image |  |
|---|---|
| Description | scientific article published on 4 April 2017 |
| Author/s |
author: Hidetsugu Nakayama Yuichi Nagakawa |
| Publication date | April 4, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |